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MouseRunx1 is highly expressed in chondroprogenitor and osteoprogenitor cells and in vitro experiments suggest
that Runx1 is important in the early stages of osteoblast and chondrocyte differentiation. However, because
Runx1 knockout mice are early embryonic lethal due to failure of hematopoiesis, the role of Runx1 in
skeletogenesis remains unclear. We studied the role of Runx1 in skeletal development using a Runx1
reversible knockout mouse model. By crossing with Tie2-Cre deletor mice, Runx1 expression was selectively
rescued in the endothelial and hematopoietic systems but not in the skeleton. Although Runx1Re/Re embryos
survived until birth and had a generally normal skeleton, the development of mineralization in the sternum
and some skull elements was signiﬁcantly disrupted. In contrast to wild-type embryos, the sternum of E17.5
Runx1Re/Re embryos showed high levels of Sox-9 and collagen type II expression and lack of development of
hypertrophic chondrocytes. In situ hybridization analysis demonstrated that, in contrast to the vertebrae and
long bones, the sternum of wild-type embryos expresses high levels of Runx1, but not Runx2, the master
regulator of skeletogenesis. Thus, although Runx1 is not essential for major skeletal development, it does play
an essential role in the development of the sternum and some skull elements.'t Hof).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The Runx family genes, Runx1, 2, and 3, encode transcription
factors that are important regulators of development and differenti-
ation (Otto et al., 2003; Levanon and Groner, 2004). All three Runx
proteins share a high degree of sequence homology, with the highest
degree in the DNA binding sequence, the so-called runt homology
domain, named because of its sequence homology to the Drosophila
transcription factor runt (Otto et al., 2003; Levanon and Groner,
2004). All three Runx proteins form heterodimers with the transcrip-
tional coactivator core binding factor β (Cbfb) and recognize the same
consensus sequence, PyGPyGGTPy (Komori and Kishimoto, 1998).
The speciﬁcity of their actions is believed to depend, for a large part,
on the timing and lineage speciﬁcity of their expression. Furthermore,
posttranslational modiﬁcations such as phosphorylation and acetyla-
tion may alter their activity, and there are substantial differences
between the three Runx proteins in this respect (Bae and Lee, 2006).Runx2, also known as AML3 and Cbfa1, acts as a master switch in
the development of osteoblasts (Lian et al., 2006), and knockout mice
deﬁcient for Runx2 (Runx2−/−) completely lack a bony skeleton,
although the cartilage develops normally (Otto et al., 1997; Komori
et al., 1997). Mutations in the Runx2 gene have been found to cause
cleidocranial dysplasia in humans (Mundlos et al., 1997; Otto et al.,
2002). Another family member, Runx3, also known as AML2, plays a
role in the development of certain neurons, as Runx3-deﬁcient mice
suffer from severe limb ataxia due to a loss of dorsal root ganglia
proprioceptive neurons (Levanon et al., 2002; Inoue et al., 2003). In
one strain of Runx3−/− mice, hyperplasia of the gastric mucosa was
also detected (Li et al., 2002). Runx1, also known as AML1 and Cbfa2,
has been shown to be essential for hematopoietic development, and
mice deﬁcient for Runx1 (Runx1−/−) die early during embryonic
development due to a failure of fetal liver hematopoiesis and hemor-
rhages in the central nervous system (Okuda et al., 1996; Wang et al.,
1996). Runx1+/− heterozygote animals develop normally, and no
skeletal abnormalities have been reported (Lian et al., 2003). It has
also been shown that Runx1 plays an essential role in neuronal devel-
opment (Stifani et al., 2008). Although Runx1 is essential for the
establishment of deﬁnitive hematopoiesis during embryonic devel-
opment, its expression pattern suggests an additional role in skeletal
development. It has been shown that Runx1 is expressed in pre-
chondrocytic tissue, resting zone chondrocytes, suture lines of the
Fig. 1. The ﬂoxed LacZ-stop cassette is not excised in the skeletons of Runx1Re/Re
embryos. Wild-type (A) and Runx1Re/Re (B) embryos were stained for β-galactosidase
to assess expression of the LacZ reporter/stop cassette. No speciﬁc β-galactosidase stain
is present in the wild type embryo, whereas skeletal elements in the Runx1Re/Re embryo
stain strongly for β-galactosidase, indicating that the reporter/stop cassette is retained
in skeletal structures of Runx1Re/Re embryos.
Fig. 2. Visualization of the skeletons of E18.5 embryos. (A) Alizarin Red/Alcian Blue staining o
gross appearanceof the skeletonof E18.5Runx1Re/Re embryos is normal, note theabsence of ste
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developing embryos (Lian et al., 2003; Yamashiro et al., 2004).
Furthermore, coexpression of Runx1 and Runx2 was detected in the
mesenchymal condensations during early skeletal development
(Yamashiro et al., 2004; Smith et al., 2005; Wang et al., 2005). In
vitro experiments showed that Runx1 and Runx2 are coexpressed
during the early differentiation of skeletal mesenchymal cells, but
Runx1 expression declines during maturation of chondrocytes and
osteoblasts (Lian et al., 2003; Wang et al., 2005). Overexpression of
Runx1 in these cells leads to the induction of chondrocyte differen-
tiation, whereas knockdown of Runx1 leads to inhibition of Runx2
expression and chondrocyte and osteoblast differentiation (Wang
et al., 2005). Accordingly, deﬁciency of the CBFβ subunit, which is
essentially involved in all Runx family transcription complexes,
results in severe abnormalities in skeletogenesis (Yoshida et al.,
2002; Kundu et al., 2002).
Owing to the early lethality of the Runx1−/− embryos, it has, so far,
not been possible to establish whether Runx1 is essential for skeletal
development in vivo. We recently developed a reversible knockout/
reporter mouse model in which the Runx1 locus is disrupted by a
LacZ-stop cassette ﬂanked by loxP sites (Samokhvalov et al., 2006).
Restoration of the integrity of the Runx1 locus using Cre-mediated
recombination in the germ line results in the production of normal
viable mice. Here, by crossing with Tie2-Cre deletor mice, we
selectively rescued Runx1 expression in endothelial and hematopoi-
etic cells in Runx1−/− embryos without restoring Runx1 function in
the skeleton. Using this model, we show that Runx1 plays a
nonredundant essential role in ossiﬁcation of the sternum and
participates in ossiﬁcation of the occipital bone. We link this ﬁnding
with the observation that, in contrast to other parts of the skeleton,
the sternum expresses high levels of Runx1 and almost undetectablef E18.5 embryos. (B) Micro-CT imaging of mineralized bones in E18.5 embryos. Although
rnebrae (indicatedbywhite arrows) andnonfusionof the supraoccipital bone(redarrow).
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context, different members of the Runx family may play functionally
similar roles.
Materials and methods
Generation of transgenic animals
Mice carrying a LoxP-ﬂanked LacZ-stop cassette inserted into the
5′-untranslated region downstream of the proximal promoter
(Runx1+/LacZ) were generated as previously described (Samokhvalov
et al., 2006). The insert abolishes the expression of all Runx1
transcripts. The Runx1+/LacZ mice were crossed with mice expressing
Cre under control of the TIE2 promoter (Kisanuki et al., 2001).
The [Tie2-Cre+/−::Runx1+/LacZ] males were further crossed with
Runx1+/LacZ females. Embryos and adult animals from these cross-
ings were genotyped by Southern blot hybridization (Samokhvalov
et al., 2006). Brieﬂy, blood and tail samples were obtained fromFig. 3. Disrupted development of the sternum in Runx1Re/Re embryos. (A) Alizarin Red/Alcian
The Runx1+/Re sternum shows an intermediate phenotype. At E18.5, sternebrae are present in
and the Runx1+/Re sternum. (B, C) Analysis of the E18.5 sternum by µCT. The Runx1Re/Re ster
mineralized bone volume (C). The Runx1+/Re sternum shows an intermediate phenotype. ⁎embryos; genomic DNA was isolated and digested by the NheI
enzyme and hybridized concurrently with A and Cre probes
(Samokhvalov et al., 2006). Embryos carrying TIE2-Cre and homo-
zygous for the reactivated allele were identiﬁed as Runx1Re/Re. No
adult animals of the Runx1Re/Re genotype were obtained from this
crossing. The mice were generated and kept in the ISCR animal
house facilities in accordance with Home Ofﬁce (UK) regulations.
Skeletal analysis
Day 18.5 embryos were ﬁxed in phosphate-buffered formalin (4%),
and the skeleton was imaged by µCT using a Skyscan 1172 (60 kV,
150 µA), at a resolution of 20 µm. The images were reconstructed
using the Skyscan NRecon program and analyzed using Skyscan CTAN
and CTVol software. Other embryos were harvested at E17.5 and
E18.5, and the skeleton was stained using Alcian Blue and Alizarin
Red. The embryos were photographed on a light box using a Canon
30D digital camera ﬁtted with a 100-mm macro lens.Blue staining. Note the absence of sternebrae (red) in the Runx1Re/Re sternum at E17.5.
the Runx1Re/Re sternum, but the number and size are decreased compared to wild-type
num shows a reduction in number of mineralized sternebrae (B) and a large decrease in
pb0.05, Runx1+/+: n=4, Runx1+/Re: n=5, Runx1Re/Re: n=3.
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Embryos were ﬁxed in phosphate-buffered formalin (4%) and
embedded inparafﬁnwax. Sections (7 µm)were cut and either stained
using Mason's trichrome or processed for in situ hybridization. 35S in
situ hybridization on parafﬁn sections was performed as previously
described (Vainio et al., 1993). The preparation of the following RNA
probes has been described: Bsp (Rice et al., 2003), Runx1, Runx2, Runx3
(Yamashiro et al., 2002), Col II (Metsaranta et al., 1991), and Sox9
(Morais et al., 1996). Both bright- and dark-ﬁeld images were taken
from hybridized sections. Silver grains were selected from the dark-Fig. 4. Reduced hypertrophy and osteoblast development in the sternum of E17.5 Runx1R
embryos. Hypertrophic zones are clearly visible in the wild-type embryo (arrows) but vir
markers was studied by in situ hybridization. Note the lack of staining for collagen type II (CO
high level of staining for bothmarkers over the entire sternum in the Runx1Re/Re embryo. In w
high levels of the mature osteoblast marker Bone sialoprotein (Bsp). However, in the Runx1ﬁeld image, colored red, and then superimposed into the identical
bright-ﬁeld image using Adobe Photoshop 6.0 software.
Statistical analysis
Statistical analysis was performed using SPSS forWindows version
11. Signiﬁcant differences between groups were determined by
ANOVA. If more than 2 groups were compared, signiﬁcant differences
were determined using the Bonferroni correction. All data are
presented as means±SEM unless stated otherwise. Values of p less
than 0.05 were considered signiﬁcant.e/Re embryos. (A) Hematoxylin and eosin staining of E17.5 wild-type and Runx1Re/Re
tually absent in the Runx1Re/Re embryo. (B) Expression of chondrocyte and osteoblast
L II) and Sox9 in the hypertrophic zones of the wild-type embryo. In contrast, there is a
ild-type embryos, the perichondrium (bone collar) of the hypertrophic zones expresses
Re/Re sternum, Bsp was not expressed.
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Unlike Runx1LacZ/LacZ embryos, Runx1Re/Re embryos survived past
E12. The hematopoietic system of Runx1Re/Re embryos was rescued as
they developed myeloid progenitors in the yolk sac and deﬁnitive
hematopoietic stem cells (HSCs) in fetal liver capable of long-term
multilineage repopulation of adult animals (Liakhovitskaia et al.,
2009). To conﬁrm that Runx1 is knocked out in the skeletons of the
Runx1Re/Re embryos, the embryos were stained for β-gal expression
(Fig. 1). All Runx1Re/Re embryos showed dark blue staining of the
skeleton, indicating that the reporter/stop cassette preventing Runx1
expression remained undeleted in the skeleton. Despite reconstitu-
tion of the hematopoiesis, Runx1Re/Re mice died shortly after birth.
Surprisingly, the skeletal cartilage appearedmostly normal in Alcian
Blue/Alizarin Red stained E18.5 Runx1Re/Re embryos (Fig. 2A). Although
the Runx1Re/Re embryos showed a predominantly normal skeleton atFig. 5. Expression of Runx isoforms in the developing skeleton. Expression of the three Run
limbs, expression of Runx2 and Runx3 is associated with sites of endochondral ossiﬁcation, R
the sternum.this age (Fig. 2B), they lacked sternebrae, the mineralization centers in
the sternum (Fig. 2B). In detail examination of the sternum from E17.5
embryos showed a complete lack of Alizarin Red stain in the Runx1Re/Re
embryos, whereas in Runx1+/Re embryos, sternebrae were present but
reduced in number and size (Fig. 3A). By E18.5, sternebrae had
developed in Runx1Re/Re embryos but were considerably less developed
than in the Runx1+/Re and wild-type (Runx1+/+) embryos (Fig. 3A).
Micro-CT analysis showed a signiﬁcantly reduced amount of mineral-
ized tissue in the sternum of E18.5 Runx1Re/Re embryos and an
intermediate mineralized tissue volume in the sternum of Runx1+/Re
embryos (Figs. 3B and C). Histological analysis of the sternum of E17.5
Runx1Re/Re embryos showed that hypertrophic chondrocytes were
absent, whereas clearly deﬁned bands of hypertrophic chondrocytes
were present in the sternum of Runx1+/+ embryos (Fig. 4A). In situ
hybridization showedwidespread expression of both Sox-9 and collagen
type II throughout the sternum of the E17.5 Runx1Re/Re embryos,x isoforms at E17.5 was studied by in situ hybridization. Whereas in the vertebrae and
unx2 and Runx3 are undetectable in the sternum. In contrast, Runx1 levels were high in
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proliferating zones (Fig. 4B), indicating that most of the cells in the
Runx1Re/Re sternum were immature proliferating chondrocytes. At the
same time (E17.5), the mature osteoblast marker bone sialoprotein
(Bsp) was clearly detected in Runx1+/+ embryos in well-deﬁned areas
lining the hypertrophic chondrocytes, whereas its expression was
undetectable in Runx1Re/Re embryos. Interestingly, Runx1 expression
levels were high in the wild-type sternum, whereas Runx2 and Runx3
were almost undetectable. In contrast, Runx1 expression in osteoblasts
of the vertebrae and longbones of Runx1+/+embryoswas undetectable
but, as expected, showed high Runx2 expression (Fig. 5).
Previous investigations have shown Runx1 expression in the skull,
with high levels of expression in the sutures of the calvaria (Yamashiro
et al., 2002; Lian et al., 2003; Yamashiro et al., 2004). We therefore
carefully examined the skull bones of the Runx1Re/Re mice. Although
gross anatomy of the skull bones was normal in these mice, we noticed
abnormal development of several structures. In E16.5 Runx1Re/Re
embryos, histological analysis showed that there is a cleft between the
primary and secondary palatal shelves, which extends a short distance
caudally between the two secondary palatal shelves (Figs. 6A and B).
More caudal to the cleft, thepalatal shelves fused. InRunx1+/+ embryos,
the palatal shelves had fused normally (Fig. 6A and B). Interestingly, in
situhybridization showedhigh expression levels of Runx1 at themidline
of the palate, with relatively little Runx2 expression, and Runx3 was
undetectable (Fig. 6C). Micro-CT analysis showed abnormal develop-Fig. 6. Runx1 has a role in the developing palate. (A and B) E16.5 mouse embryo sagittal (A) a
cleft between the primary and secondary palatal shelves (black arrow). The cleft extends a sh
the cleft, the palatal shelves fused. (C) Expression of the three Runx isoforms in wild-type pa
Runx1 is highly expressed at the site of fusion of the palatal shelves. Modest expression of Run
nasal cavity; ns, nasal septum; pp, primary palatal shelves; sp, secondary palatal shelves; tment of the occipital bone in E18.5 Runx1Re/Re embryos (Fig. 7A). In
Runx1+/+ embryos the occipital plates had fused, whereas this was not
the case in the Runx1Re/Re embryos. Furthermore, volumetric analysis of
the heterozygous Runx1+/Re embryos showed a signiﬁcant reduction in
occipital bone volume, consistent with a phenotype intermediate
between wild-type and Runx1Re/Re embryos (Fig. 7B). In sections of
E16.5 embryos, mineralized bone is clearly detectable in Runx1+/+
embryos, whereas the occipital plate consists entirely of cartilage in
Runx1Re/Re embryos (Fig. 7C).
Discussion
The expression pattern of Runx1 during embryonic development
suggests that this transcription factor plays a part in skeletal
development. Because Runx1 is essential for the development of the
hematopoietic system, Runx1−/− embryos die around E12 due to
severe anemia, the role of Runx1 in skeletal development cannot be
studied in these traditional knockouts. Here, we have studied skeletal
development in the Runx1Re/Re embryos, which are deﬁcient in Runx1
in all cells except endothelial and hematopoietic ones. Surprisingly,
the development of skeletal cartilage was almost completely normal
in these embryos, indicating that Runx1 is not essential for cartilage
development. This is in contrast to in vitro studies, which showed that
knockdown of Runx1 in mesenchymal cells inhibited chondrocytic
differentiation and that overexpression of Runx1 induced this processnd frontal (B) sections stained with Masson trichrome. In Runx1Re/Re embryos, there is a
ort distance caudally between the secondary palatal shelves (red arrow). More caudal to
late at E14.5 studied by in situ hybridization. Runx3 expression is undetectable, whereas
x2 is present in the palatal bone primordia. mm,mandibular molar tooth primordia; nc,
, tongue; ui, upper incisor tooth primordial; max, maxilla; man, mandible.
Fig. 7. Delayed development of the occipital bone in Runx1Re/Re embryos. (A, B) Analysis of the E18.5 supraoccipital bone by µCT. In contrast to the wild-type embryo, the
supraoccipital bones have not fused yet in the Runx1Re/Re embryo (A) and bone volume is substantially decreased (B). The Runx1+/Re embryo shows an intermediate phenotype.
⁎pb0.05, Runx1+/+: n=4, Runx1+/Re: n=5, Runx1Re/Re: n=3. (C) Masson trichrome staining of the supraoccipital bone in E16.5 embryos. In wild-type embryos, bone has clearly
formed (arrow), and this led to tearing of the section during sectioning. No mineralized bone was observed in sections of Runx1Re/Re embryos.
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signiﬁcantly disrupted in the sternum and in several bones in the
skull. The expression levels of Runx1 were relatively high in these
developing bones in wild-type embryos. In line with this, the
intermediate phenotype of these tissues in heterozygous Runx1+/Re
embryos suggests a gene dose effect. It is striking that the bone
structure, which is most strongly affected in the Runx1Re/Re mice, the
sternum, expresses high levels of Runx1 and relatively low levels of
Runx2 and Runx3 in wild-type embryos. This suggests that osteoblast
development in this bone is predominantly driven by Runx1.
However, because Runx2−/− embryos completely lack mature
osteoblasts, also in the sternum, Runx1 alone is clearly not sufﬁcient
to initiate osteoblast development. There could be a synergistic effect
of Runx1 and Runx2 on target genes. Interestingly, missing mineral-
ization centers in one or more sternebrae is quite common in young
children (Rush et al., 2002). Our results suggest that this may be
related to the different, Runx1-driven, regulation of bone develop-
ment in this skeletal element. The cleft palate phenotype was recently
also described by Charoenchaikorn et al. (2009) who used a similar
approach to rescue Runx1 expression in hematopoietic cells. The bone
tissue in the palatal shelves appeared normal, and the Runx1 expres-
sionwas observed predominantly in the soft tissue at the site of fusion
of the palatal shelves, suggesting that the cleft was due to a defect in
this soft tissue rather than the bone of the palatal shelves.
All three Runx proteins bind to the same consensus sequence. It is
therefore possible that Runx2 and Runx3 can compensate for the lack ofRunx1 in most developing skeletal structures. Like Runx1, Runx3 is
expressed during the early skeletogenesis (Stricker et al., 2002; Soung et
al., 2007), and recent in vitro experiments have shown that Runx3
overexpression stimulates chondrogenic differentiation, while knock-
down inhibits this process (Soung et al., 2007). However, the only
skeletal defect reported in Runx3−/− mice is a small delay in
chondrocyte maturation (Yoshida et al., 2004). It is therefore possible
that there is a large amount of redundancy in the roles of the Runx
proteins during early skeletogenesis and that severe defects will only
become apparent in double- or triple-knockout animals. Indeed, while
single Runx knockouts show relatively mild effects on chondrocyte
development, the Runx2–Runx3 double knockout mice showed severe
defects in chondrocyte maturation (Yoshida et al., 2004). However, the
Runx2−/−Runx3−/− compound embryos showed only mild effects on
early chondrogenesis (Yoshida et al., 2004), and it is possible that, at this
stage,Runx1 can compensate for the loss of theother twoproteins. There
was also a distinct Runx3 gene dose effect because Runx2−/−Runx3+/−
embryos showed an intermediate phenotype, comparable to our
ﬁndings in Runx1+/Re embryos.
The mouse model described here provides a unique tool to
investigate the role of Runx1 in various nonendothelial and nonhema-
topoietic tissues, which remain completely Runx1-negative. Despite
rescue of the hematopoietic system (Liakhovitskaia et al., 2009), the
Runx1Re/Re mice die at birth. One likely reason is that the development
andmaintenance of certain Runx1-expressing neurons in thesemice are
severely affected (Stifani et al., 2008). Here, we found that the sternum
546 A. Liakhovitskaia et al. / Developmental Biology 340 (2010) 539–546in these animals is not properly mineralized, which can also have a
signiﬁcant effect on the viability of the animals because a certain rigidity
of the rib cage required for the normal breathingmay be compromised.
In conclusion, although Runx1 is not essential for major skeletal
development, it does play a role because the development of several
skeletal elements is disrupted in theRunx1Re/Re embryos. This correlates
with high levels of Runx1 expression in these skeletal elements. Future
experiments involving Runx1Re/Re embryos that are also deﬁcient in
Runx2 or Runx3 could give further insight in the level of redundancy of
the Runx family, especially in the early stages of skeletal development.
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